Axon Launches $1B Convertible Notes Offering to Fund Growth
AXON sits 40% above its 52-week low of $339.01.
Summary
Axon announced a proposed $1.0 billion offering of 0% convertible senior notes due September 15, 2031, with an additional $150 million over-allotment option. The company plans to use proceeds for general corporate purposes, including potential acquisitions, and will enter capped call transactions to mitigate dilution. This is a significant capital raise for a company with a market cap near $40 billion, and the zero-coupon structure reflects strong investor demand for Axon's equity-linked paper. The offering follows a strong Q2 with 35% revenue growth and recent insider selling by the CEO under pre-existing plans. Pricing set initial conversion price at about $652.06 per share, a 47.5% premium over the $442.08 last sale, with a capped call cap price of $1,049.94. Net proceeds are estimated at $986.0 million, with $99.9 million used for capped calls. Axon also expanded its revolving credit facility from $300 million to $500 million, extendable by $150 million.
Updated with an SEC FWP filing · What changed
Updates
· SEC FWP — Pricing set initial conversion price at about $652.06 per share, a 47.5% premium over the $442.08 last sale, with a capped call cap price of $1,049.94. Net proceeds are estimated at $986.0 million, with $99.9 million used for capped calls.
· SEC 424B5 — The 424B5 sets the notes' maturity at September 15, 2031, with no regular interest, and expands the revolving credit facility from $300 million to $500 million, extendable by $150 million.
At the time of this announcement, AXON was trading at $475.29 on NASDAQ in the Technology sector, with a market capitalization of approximately $39.8B. The 52-week trading range was $339.01 to $792.16. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: PR Newswire.